EI
ORIC icon

Ellevest Inc’s Oric Pharmaceuticals ORIC Stock Holding History

Ellevest Inc’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-156
Closed -$1K – 1785
2022
Q2 		$1K Buy
156
+143
+1,100% +$571 ﹤0.01% 1299
2022
Q1 		$0 Buy
13
+5
+63% +$45 ﹤0.01% 1575
2021
Q4 		$0 Buy
+8
New +$125 ﹤0.01% 1579

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ellevest Inc's ORIC Position: Q3 2022 in Review

Ellevest Inc sold out of Oric Pharmaceuticals (ORIC) in Q3 2022, closing a stake of 156 shares — an estimated $1K sold.

Ellevest Inc first reported a position in ORIC in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 76 funds tracked by Wall St. Rank hold ORIC as of Q3 2022.

  • Ellevest Inc reported no remaining Oric Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 156 Oric Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Ellevest Inc first reported a position in Oric Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Ellevest Inc's Oric Pharmaceuticals position peaked at $1K in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.